Accumulated data suggest that the Wnt signaling exerts its oncogenic functions via upregulation of target genes involved in cell proliferation, exemplified by the β-catenin/TCF transcriptional effects on c-Myc expression in carcinomas [20, 21], and CDC25A recently identified in sarcomas [22]. The gene discussed is HNF4A; the disease is sarcoma.